UBS Group’s Dermata Therapeutics, Inc. Warrant DRMAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34 | Sell |
1,880
-737
| -28% | -$13 | ﹤0.01% | 8755 |
|
|
2025
Q1 | $44 | Sell |
2,617
-1,525
| -37% | -$26 | ﹤0.01% | 8707 |
|
|
2024
Q4 | $46 | Sell |
4,142
-100
| -2% | -$1 | ﹤0.01% | 8466 |
|
|
2024
Q3 | $42 | Sell |
4,242
-800
| -16% | -$8 | ﹤0.01% | 8033 |
|
|
2024
Q2 | $71 | Buy |
5,042
+3,557
| +240% | +$50 | ﹤0.01% | 8039 |
|
|
2024
Q1 | $15 | Sell |
1,485
-1,868
| -56% | -$19 | ﹤0.01% | 7886 |
|
|
2023
Q4 | $23 | Sell |
3,353
-2,257
| -40% | -$15 | ﹤0.01% | 7847 |
|
|
2023
Q3 | $101 | Buy |
+5,610
| New | +$101 | ﹤0.01% | 7734 |
|
|
2023
Q2 | – | Sell |
-1,800
| Closed | -$36 | – | 7929 |
|
|
2023
Q1 | $36 | Sell |
1,800
-5,105
| -74% | -$102 | ﹤0.01% | 8268 |
|
|
2022
Q4 | $138 | Sell |
6,905
-2,195
| -24% | -$44 | ﹤0.01% | 9158 |
|
|
2022
Q3 | $1K | Buy |
+9,100
| New | +$1K | ﹤0.01% | 8835 |
|
|
2022
Q2 | – | Sell |
-3,267
| Closed | -$1K | – | 9334 |
|
|
2022
Q1 | $1K | Sell |
3,267
-3,693
| -53% | -$1.13K | ﹤0.01% | 8799 |
|
|
2021
Q4 | $3K | Buy |
6,960
+3,960
| +132% | +$1.71K | ﹤0.01% | 8525 |
|
|
2021
Q3 | $2K | Buy |
+3,000
| New | +$2K | ﹤0.01% | 7786 |
|